BACE1 and Alzheimer disease: Moreover, this effect of SDP is comparable to that of other nutritional interventions, which include supplementation with vitamin D, resveratrol, and lycopene, compounds, that also reduce the levels of Aβ-related biomarkers, such as APP, sAPPβ, and BACE1, in both mice and patients with AD [40,41,42].